Table 2.
Avg. ± Std. Dev | Median | Maximum | Percentiles | ||
---|---|---|---|---|---|
25th | 75th | ||||
PAH metabolites (ng mL−1)c | |||||
2-Nap | 4.20 ± 2.85 | 3.89 | 8.90 | 1.80 | 7.35 |
ΣOH-Flua | 0.53 ± 0.5 | 0.36 | 2.52 | 0.25 | 0.70 |
ΣOH-Pheb | 1.64 ± 1.16 | 1.29 | 6.97 | 1.09 | 1.66 |
1-OH-Pyr | 0.51 ± 0.72 | 0.31 | 4.02 | 0.27 | 0.48 |
Other biomarkers (ng mL−1)c | |||||
4-HNE-MA | 89 ± 63 | 83 | 226 | 40 | 135 |
8-oxodG | 8.1 ± 3.5 | 7.3 | 18.3 | 5.6 | 9.1 |
3-HPMA | 1000 ± 820 | 790 | 3170 | 450 | 1160 |
Individual urinary concentrations are presented in Table S4
aSum of 2- and 3-OH fluorene
bSum of Σ2,3-OH phenanthrene, 1-OH phenanthrene and 4-OH phenanthrene
cThe urinary metabolites were adjusted for urine density